Saccharomyces boulardii Inhibits EGF Receptor Signaling and Intestinal Tumor Growth in Apcmin Mice-Reference-Cited by-同舟云学术

Saccharomyces boulardii Inhibits EGF Receptor Signaling and Intestinal Tumor Growth in Apcmin Mice

Published:2009-09 Issue:3 Volume:137 Page:914-923
ISSN:0016-5085
Container-title:Gastroenterology
language:en
Short-container-title:Gastroenterology

Author:

Chen Xinhua,Fruehauf Johannes,Goldsmith Jeffrey D.,Xu Hua,Katchar Kianoosh K.,Koon Hon–Wai,Zhao Dezheng,Kokkotou Efi G.,Pothoulakis Charalabos,Kelly Ciarán P.

Publisher

Elsevier BV

Subject

Gastroenterology,Hepatology

Reference38 articles.

1. Biotherapeutic agents;Elmer;JAMA,1996

2. The place of probiotics in human intestinal infections;Sullivan;Int J Antimicrob Agents,2002

3. Saccharomyces boulardii in maintenance treatment of Crohn's disease;Guslandi;Dig Dis Sci,2000

4. Saccharomyces boulardii protease inhibits Clostridium difficile toxin A effects in the rat ileum;Castagliuolo;Infect Immun,1996

5. Saccharomyces boulardii preserves the barrier function and modulates the signal transduction pathway induced in enteropathogenic Escherichia coli-infected T84 cells;Czerucka;Infect Immun,2000

Cited by 73 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Colorectal cancer and gut microbiota studies in China;Gut Microbes;2023-07-23

2. Fungi and cancer;Gut;2023-05-05

3. Intestinal Engineered Probiotics as Living Therapeutics: Chassis Selection, Colonization Enhancement, Gene Circuit Design, and Biocontainment;ACS SYNTH BIOL;2022

4. Diversity of the gut, vaginal and oral microbiome among pregnant women in South Africa with and without pre-eclampsia;Frontiers in Global Women's Health;2022-09-16

5. Intestinal Engineered Probiotics as Living Therapeutics: Chassis Selection, Colonization Enhancement, Gene Circuit Design, and Biocontainment;ACS Synthetic Biology;2022-09-12